Clinical Trials
Bharat Biotech gets approval to conduct phase 2 trials of COVID-19 vaccine Covaxin
Hyderabad-based Bharat Biotech has received approval to conduct phase II trials of its COVID-19 vaccine Covaxin from September 7.
The Directorate General of Health Service...
Clinical Trials
Early trials find Russia’s Sputnik V safe, volunteers develop coronavirus antibodies within 3 weeks
Much buzz was created around the world when Russia claimed to have approved the first COVID-19 vaccine around the world, for public use. Experts...
News
CureVac to Receive 252million Euros to Support COVID-19 Vax Development
CureVac N.V., a biopharmaceutical company developing a new class of transformative medicines based on messenger ribonucleic acid (mRNA) in clinical trials, has received notification...
Drug Research
Enesi Pharma partners with Adelaide University for Zika vaccine
Enesi Pharma, an innovative biotechnology company developing next-generation vaccination products targeting serious diseases, is delighted to announce its partnership with the University of Adelaide...
Press Releases
AbbVie and I-Mab Enter Into Global Strategic Partnership for Differentiated Immuno-oncology Therapy
AbbVie and I-Mab announced that AbbVie and I-Mab have signed a broad, global collaboration agreement for the development and commercialization of lemzoparlimab (also known...
News
World’s Largest Virtual Pharma Expo Agenda Unveiled
CPhI Festival of Pharma (5-16 October, 2020), the world’s largest ever virtual pharma expo, unveils its ground-breaking two-week long agenda. The newly launched and...
Press Releases
KORSCH Introduces Next-Generation Mid-Range Tablet Press
X 3 Tablet Press incorporates production capabilities and versatility traditionally limited to large-scale production machines
State-of-the-art-tableting technology meets the midrange segment at last. The days...
Subscribe
- Never miss a story with notifications
- Gain full access to our premium content
- Browse free from up to 5 devices at once
Must read
